Peter Jarrett

Peter Jarrett, Ph.D., has more than 30 years of R&D experience, ranging from discovery to commercialization. Peter Jarrett joined Ocular Therapeutix in 2007. Previously, he was Vice President of R&D at Focal, subsequently being named VP of Biomaterials R&D at Genzyme upon the latter company’s acquisition of Focal. Peter Jarrett began his career in Corporate R&D of American Cyanamid, later moving to the Davis and Geck division. At Cyanamid, Focal, Genzyme and Ocular, Peter Jarrett developed bioresorbable polymers for medical devices and drug delivery systems, resulting in numerous patents and publications. Peter Jarrett holds a B.A. degree in Chemistry from Connecticut College and a Ph.D. degree in Polymer Science from the University of Connecticut Institute of Materials Science.

Peter Jarrett is the Chief Scientific Officer at Ocular Therapeutix, based in United States, North America. With a background in Biotechnology, Peter Jarrett has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.